TAILIEUCHUNG - Colorectal cancer screening

Document introduction of content: Introduction, methodology and literature review; epidemiology of colorectal cancer; screening tests and evidence - Stool tests, occult blood, and DNA; screening tests and evidence - Endoscopy and CT colonography, cost-Effectiveness of CRC screening; cascades – Tooling up for screening, where to get help, useful web sites, guidelines and selected references. | Colorectal cancer screening World Gastroenterology Organisation International Digestive Cancer Alliance Practice Guidelines Colorectal cancer screening Review team Prof. S. Winawer chair USA Prof. M. Classen co-chair Germany Prof. R. Lambert co-chair France Prof. M. Fried Switzerland Prof. P. Dite Czech Republic Prof. . Goh Malaysia Prof. F. Guarner Spain Prof. D. Lieberman USA Prof. R. Eliakim Israel Prof. B. Levin USA Prof. R. Saenz Chile Prof. . Khan Pakistan Prof. I. Khalif Russia Prof. A. Lanas Spain Prof. G. Lindberg Sweden Prof. . O Brien USA Prof. G. Young Australia Dr. J. Krabshuis France International consultants Prof. R. Smith USA Prof. W. Schmiegel Germany Prof. D. Rex USA Prof. N. Amrani Morocco Prof. A. Zauber USA World Gastroenterology Organisation 2007 Colorectal cancer screening Contents 1 Introduction 2 Methodology and literature review 3 Epidemiology of colorectal cancer 4 Screening tests and evidence 1 stool tests occult blood and DNA 5 Screening tests and evidence 2 endoscopy and CT colonography 6 Cost-effectiveness of CRC screening 7 Cascades - tooling up for screening 8 Where to get help 9 Useful web sites guidelines and selected references 10 Queries and feedback 1 Introduction Colorectal cancer CRC is a worldwide problem with an annual incidence of approximately 1 million cases and an annual mortality of more than 500 000. The absolute number of cases will increase over the next two decades as a result of the aging and expansion of populations in both the developed and developing countries. CRC is the second most common cause of cancer mortality among men and women. Most CRCs arise from sporadic adenomas and a few from genetic polyposis syndromes or inflammatory bowel disease IBD . The term polyp refers to a discrete mass that protrudes into the intestinal lumen. The reported prevalence of adenomatous polyps on the basis of screening colonoscopy data is in the range of 18-36 . The risk for CRC varies from country to country and .

• Y khoa - Dược
• Colorectal cancer screening
• Methodology and literature review
• Epidemiology of colorectal cancer
• Screening tests and evidence
• Screening tests and evidence
• Tooling up for screening
• BMC Cancer
• Colorectal cancer
• Advanced neoplasm
• Cost effectiveness analysis
• Fecal immunochemical tests
• Stomach cancer screening
• Lung cancer survivor
• Physician recommendation
• Colorectal advanced neoplasia
• Screening colonoscopy
• Risk assessment
• Self regulation
• Micro actions
• Screening intention
• BMC Psychology
• CRC screening
• Cancer screening
• Decision making
• Decision making styles
• Fecal immunochemical test
• Colonic polyps
• Healthy Lifestyle
• Lifestyle predictors
• FIT screening
• Colorectal neoplasms
• Physician recommendations
• CRC screening modalities
• Primary screening method
• Mass screening
• Hispanic Americans
• Psychological theory
• Health behavior
• Gastric cancer screening
• Participation rate
• Invitation letter
• Target age group
• Faecal Occult Blood test
• Non significance
• Early detection
• First degree relatives
• Non compliance
• Metropolitan areas
• Medical tourism
• Korean Americans
• Colorectal neoplasm
• Early detection of cancer
• Primary health care
• Chronic disease
• Clorectal neoplasm
• Fecal occult blood test
• Identifying preferences
• Budget impact analysis
• Delay seeking healthcare
• Demographic factors
• Patient navigation
• Realistic evaluation
• Implementation research
• Health inequalities
• Randomized control study
• Cluster randomized controlled trial
• Patient decision aid
• Knowledge exchange
• Faecal occult blood test Faecal immunochemical test
• Colonoscopy
• Colorectal
• Cancer
• Screening
• Marco Bustamante
• Health
• Sciences
• medicine
• pharmacolocy
• Cost effectiveness
• Fecal occult blood testing
• Gastroenterology
• Future Directions
• Colorectal Tumours
• Sub Mucosal Invasion
• Polypectomy
• Colonic Perforation
• Cell death
• Cancer stem cell
• Intrinsic apoptosis pathway
• Induced cell death